QDEL.NASDAQQuidelortho CORP

4/A: QuidelOrtho CFO Amends Insider Stock Purchase Price

Sentiment:

Insider Transaction Amendment


QuidelOrtho's Chief Financial Officer, Joseph M. Busky, filed an amended Form 4 to correct the reported purchase price of 3,370 shares of common stock.

Summary

  • Joseph M. Busky, Chief Financial Officer of QuidelOrtho Corp (QDEL), filed an amended Form 4 on February 19, 2026.
  • The amendment corrects the pricing for 3,370 shares of common stock that were purchased on February 13, 2026.
  • The corrected weighted average purchase price for these shares is $23.6623 per share.
  • The purchase price for the shares ranged from $23.0150 to $23.6750 per share.
  • Following this transaction, Busky beneficially owns 10,290 shares indirectly through a trust.
  • Busky also directly owns 41,412 shares of QuidelOrtho common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as slightly positive due to the insider purchase by the CFO, indicating confidence, although the filing's primary purpose is an administrative price correction.

Positives

  • An insider, the Chief Financial Officer, purchased 3,370 shares of company common stock, which can signal management confidence in the company's future prospects.

Future Outlook

This filing is an amendment to an insider transaction report and does not contain forward-looking statements or guidance regarding the company's future outlook.

Management Comments

  • Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.

Industry Context

StockSavvy.ai notes that insider purchases, even small ones, can sometimes be interpreted by the market as a signal of management's confidence in the company's future prospects, especially when made by a key executive like the CFO. This specific filing, however, is primarily an administrative correction to a previously reported transaction.

Comparison to Industry Standards

  • This filing is an insider transaction report and does not contain information suitable for comparison to industry-specific operational or financial benchmarks. It reflects an individual executive's investment decision.

Stakeholder Impact

  • Shareholders: The insider purchase by the CFO could be seen as a positive signal of confidence in the company's value, despite the filing being an administrative correction.

Next Steps

  • The Reporting Person undertakes to provide full information regarding shares purchased at each separate price upon request from the SEC, the Issuer, or a security holder.

Key Dates

DateDescription
02/13/2026Date of the original transaction and original Form 4 filing.
02/19/2026Date of the amended Form 4 filing.

Recommendation

hold

The filing details an administrative correction to an insider stock purchase by the CFO. While insider buying can be a positive signal, this specific amendment does not provide new fundamental information to warrant a change in investment recommendation. The purchase itself, while positive, is not substantial enough to drive a 'buy' recommendation on its own, and the correction is neutral.

Keywords

QuidelOrtho, QDEL, Insider Trading, Form 4/A, Stock Purchase, CFO, Joseph M. Busky, Beneficial Ownership, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.